There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
The purpose of this study was to define an appropriate nadir growth hormone (nGH)
cutoff for patients with acromegaly in remission using the Access Ultrasensitive human
growth hormone (hGH) assay (Beckman Coulter, Brea, CA).